K-134 | m-entrepreneurship.com

Product Name :
K-134

Search keywords :
K134

drugId :
null

Target Vo:
Phosphodiesterase 3

Target Vo Short Name :
PDE3

Moa_Name:
Phosphodiesterase 3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kowa Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Intermittent Claudication

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Simlukafusp alfa Biological Activity
Mirvetuximab Formula
beta III Tubulin Antibody: beta III Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta III Tubulin. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts